Skip to content

Short terms surgical outcome of Endoscopic transforaminal lumbar interbody fusion versus Microtubular transforaminal lumbar interbody fusion in degenerative lumbar spine Disease

Short terms surgical outcome of Endoscopic transforaminal lumbar interbody fusion versus Microtubular transforaminal lumbar interbody fusion in degenerative lumbar spine Disease: Double blind Radomize controlled trial

Status
Unknown
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20230425004
Enrollment
62
Registered
2023-04-25
Start date
2023-01-09
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Degenerative spine disease those need 1 or 2 level fusion Degenerative spine disease, Fail conservative

Interventions

Degenerative spine disease patient scheduled for TLIF in Thammasat Hospital that performed Endoscopic transforaminal lumbar interbody fusion surgery ,Degenerative spine disease patient scheduled for
Treatment,Treatment
ENDOTLIF,MIS TLIF

Sponsors

Thammasat university
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Aged 18 and 75 years Degenerative spine disease those need 1 or 2 level fusion: Degenerative disc disease low-grade spondylolisthesis spinal stenosis spondylosis, degenerative scoliosis Understand the protocol and volunteers to join study

Exclusion criteria

Exclusion criteria: Revision TLIF High-grade spondylolisthesis(grade >2) Other spinal diseases (eg, spine infection,ankylosing spondylitis, tumor, trauma, etc. ) Cognitive and psychological disorders

Design outcomes

Primary

MeasureTime frame
Post operation pain at 12 months after end of the intervention VAS score

Secondary

MeasureTime frame
Functional outcome at 12 months after end of the intervention ODI score

Countries

Thailand

Contacts

Public ContactParun Chiawchannwuttiwong

Faculty of Medicine, Thammasat university

parun.chiawchanwuttiwong@gmail.com0875665220

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026